Key result
Recombinant HMGB1 drives cardiomyocyte hypertrophy via the 14-3-3η/PI3K/Akt/NFAT3 signaling pathway.
Why the study?
The effects of high-mobility group box 1 (HMGB1) in cardiomyocyte hypertrophy remain unclear.
Exogenous recombinant HMGB1 induces cardiomyocyte hypertrophy via the 14-3-3η/PI3K/Akt/NFAT3 signaling pathway, providing mechanistic insight into inflammation-induced cardiac remodeling.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for HMGB1 in hypertrophy; leaves open its role in human heart failure and therapeutic targeting.
High‑mobility group box 1 (HMGB1) is released by necrotic cells and serves an important role in cardiovascular pathology. However, the effects of HMGB1 in cardiomyocyte hypertrophy remain unclear. Therefore, the aim of the present study was to investigate the potential role of HMGB1 in cardiomyocyte hypertrophy and the underlying mechanisms of its action. Neonatal mouse cardiomyocytes (NMCs) were co‑cultured with recombinant HMGB1 (rHMGB1). Wortmannin was used to inhibit PI3K activity in cardiomyocytes. Subsequently, atrial natriuretic peptide (ANP), 14‑3‑3 and phosphorylated‑Akt (p‑Akt) protein levels were detected using western blot analysis. In addition, nuclear factor of activated T cells 3 (NFAT3) protein levels were measured by western blot analysis and observed in NMCs under a confocal microscope. The results revealed that rHMGB1 increased ANP and p‑Akt, and decreased 14‑3‑3η protein levels. Furthermore, wortmannin abrogated the effects of rHMGB1 on ANP, 14‑3‑3η and p‑Akt protein levels. In addition, rHMGB1 induced nuclear translocation of NFAT3, which was also inhibited by wortmannin pretreatment. The results of this study suggest that rHMGB1 induces cardiac hypertrophy by regulating the 14‑3‑3η/PI3K/Akt/NFAT3 signaling pathway.
No takes yet. Share an insight, caveat, or question.
Su et al. (2021) studied Cardiomyocyte hypertrophy (n=100). Recombinant high-mobility group box 1 (rHMGB1) vs. PBS (Control) was evaluated on Cardiomyocyte hypertrophy (measured by protein content per cell, ANP and BNP levels) (p=<0.05). Recombinant HMGB1 significantly induced cardiomyocyte hypertrophy by regulating the 14-3-3η/PI3K/Akt/NFAT3 signaling pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: